Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.

Библиографические подробности
Главные авторы:	Bafadhel, M, Davies, L, Calverley, P, Aaron, S, Brightling, C, Pavord, I
Формат:	Journal article
Язык:	English
Опубликовано:	European Respiratory Society 2014

Схожие документы

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
по: Bafadhel, M, и др.
Опубликовано: (2016)

Inhaled glucocorticoids and COPD exacerbations.
по: Brightling, C, и др.
Опубликовано: (2015)

Prednisolone response in patients with COPD.
по: Pavord, I, и др.
Опубликовано: (2004)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
по: Shrimanker, R, и др.
Опубликовано: (2017)

Blood eosinophil count and exacerbation risk in patients with COPD.
по: Kerkhof, M, и др.
Опубликовано: (2017)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
по: Helen F. Ashdown, и др.
Опубликовано: (2021-02-01)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
по: Eltboli, O, и др.
Опубликовано: (2014)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
по: Barker, R, и др.
Опубликовано: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
по: Moran, AM, и др.
Опубликовано: (2020)

Eosinophils in COPD: just another biomarker?
по: Bafadhel, M, и др.
Опубликовано: (2017)

Characterising non-eosinophilic COPD
по: Hambleton, K, и др.
Опубликовано: (2015)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
по: Siddiqui, S, и др.
Опубликовано: (2018)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
по: Djamin, R, и др.
Опубликовано: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
по: Siddiqui SH, и др.
Опубликовано: (2018-11-01)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
по: Kerkhof, M, и др.
Опубликовано: (2017)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
по: Siva, R, и др.
Опубликовано: (2007)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
по: Camp, J, и др.
Опубликовано: (2018)

Prednisolone for COPD exacerbations: time for a rethink
по: Sanjay Ramakrishnan
Опубликовано: (2023-09-01)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
по: James Camp, и др.
Опубликовано: (2018-09-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
по: Shrimanker, R, и др.
Опубликовано: (2017)

Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
по: Bafadhel, M, и др.
Опубликовано: (2017)

Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation
по: Gong Y, и др.
Опубликовано: (2022-09-01)

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.
по: Bafadhel, M, и др.
Опубликовано: (2012)

Investigating blood eosinophil count thresholds in patients with COPD
по: Russell, R, и др.
Опубликовано: (2018)

Variability of blood eosinophil count and prognosis of COPD exacerbations
по: Sandra Martínez-Gestoso, и др.
Опубликовано: (2021-01-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
по: Shrimanker, R, и др.
Опубликовано: (2017)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
по: Bafadhel, M, и др.
Опубликовано: (2018)

Peripheral blood eosinophil drop-to-drop variation in patients with COPD using near patient testing: a small validation study
по: Jeffers, H, и др.
Опубликовано: (2017)

COPD exacerbations in general practice: variability in oral prednisolone courses
по: de Vries Marianne, и др.
Опубликовано: (2012-01-01)

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
по: Moran, A, и др.
Опубликовано: (2020)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
по: Claus F. Vogelmeier, и др.
Опубликовано: (2019-08-01)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
по: Haldar, P, и др.
Опубликовано: (2009)

Aspergillus fumigatus during stable state and exacerbations of COPD.
по: Bafadhel, M, и др.
Опубликовано: (2014)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
по: Barker, B, и др.
Опубликовано: (2015)

Mepolizumab for eosinophilic COPD
по: Sciurba, F, и др.
Опубликовано: (2018)

Blood eosinophil levels as a biomarker in COPD
по: Brusselle, G, и др.
Опубликовано: (2018)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
по: Russell, R, и др.
Опубликовано: (2016)

The significance of eosinophilic inflammation in COPD
по: Cooper, C, и др.
Опубликовано: (2017)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
по: Green, R, и др.
Опубликовано: (2002)

Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study
по: Jens Ellingsen, и др.
Опубликовано: (2021-12-01)